Skip to main content

Table 2 Frequency and age and sex-standardized incidence rate of CNS tumors (reference: French National Census 2000–2012) according to histological subtype and sexa

From: Increasing incidence of central nervous system (CNS) tumors (2000–2012): findings from a population based registry in Gironde (France)

Histology ICDO-code Male   Female   Total   
n % IR n % IR n % IR
Neuroepithelial tumors
 Diffuse astrocytoma 9420/3 26 1.7 0.30 16 0.8 0.17 42 1.2 0.23
 Anaplastic astrocytoma 9401/3, 9411/3 28 1.8 0.33 28 1.4 0.30 56 1.6 0.31
 Glioblastoma 9440/3, 9441/3, 9442/3 528 34.6 6.1 417 21.0 4.2 945 26.9 5.3
 Pilocytic astrocytoma 9421/1 17 1.1 0.20 17 0.9 0.19 34 1.0 0.19
 Unique astrocytoma variantsb 9383/1, 9384/1, 9424/3 12 0.8 0.14 8 0.4 0.09 20 0.6 0.11
 Oligodendroglioma 9450/3 14 0.9 0.16 14 0.7 0.14 28 0.8 0.15
 Anaplastic oligodendroglioma 9451/3 4 0.3 0.05 9 0.5 0.09 13 0.4 0.07
 Ependymoma/anaplastic ependymoma 9391/3, 9392/3 37 2.4 0.43 19 1.0 0.20 56 1.6 0.31
 Ependymoma variants (myxopapillary ependymoma) 9394/1 8 0.5 0.09 3 0.2 0.03 11 0.3 0.06
 Mixed gliomab 9382/3 51 3.3 0.59 46 2.3 0.48 97 2.8 0.53
 Astrocytoma, NOS 9400/3 20 1.3 0.23 11 0.6 0.12 31 0.9 0.17
 Glioma malignant, NOS 9380/3 27 1.8 0.31 18 0.9 0.19 45 1.3 0.25
 Choroid plexus 9390/0, 9390/1 6 0.4 0.07 4 0.2 0.04 10 0.3 0.06
 Neuroepithelial 9381/3, 9430/3 4 0.3 0.05 7 0.4 0.08 11 0.3 0.06
 Benign and malignant neuronal/glial, neuronal and mixed 8680/1, 9412/1, 9413/0, 9490/0,9492/0, 9500/3, 9505/1, 9505/3, 9506/1 32 2.1 0.37 25 1.3 0.26 57 1.6 0.31
 Pineal parenchymal 9361/1, 9362/3 2 0.1 0.02 1 0.1 0.01 3 0.1 0.02
 Embryonal/primitive/medulloblastoma 9470/3, 9471/3, 9473/3, 9508/3 27 1.8 0.32 10 0.5 0.11 37 1.1 0.21
Tumors of cranial and spinal nerves 9540/0, 9540/3, 9550/0, 9560/0 208 13.6 2.4 214 10.8 2.2 422 12.0 2.3
Meningeal Tumors
 Meningioma 9530/0, 9530/1, 9530/3, 9531/0, 9532/0, 9533/0, 9534/0, 9537/0, 9538/1, 9538/3, 9539/1 300 19.7 3.5 931 46.8 9.1 1231 35.0 6.8
 Other mesenchymal, benign and malignant 8815/0, 8830/3, 8850/0, 8861/0, 8890/3, 9150/1, 9150/3, 9180/0, 9180/3 19 1.2 0.22 21 1.1 0.21 40 1.1 0.22
 Hemangioblastoma 9161/1 27 1.8 0.31 23 1.2 0.23 50 1.4 0.27
Lymphomas 9590/3, 9591/3, 9680/3, 9731/3 57 3.7 0.66 58 2.9 0.58 115 3.3 0.64
Germ cell tumors and cystsc 9064/3, 9080/0, 9080/1, 9084/0, 9100/3 13 0.9 0.15 6 0.3 0.07 19 0.5 0.11
Tumors of the sellar region (craniopharyngiomas) 9350/1, 9351/1 21 1.4 0.24 19 1.0 0.20 40 1.1 0.22
Chordoma/chondrosarcoma 9320/0, 9220/3, 9370/3 3 0.2 0.04 10 0.5 0.11 13 0.4 0.07
Unclassified tumors 8000/1, 8000/3 35 2.3 0.40 54 2.7 0.46 89 2.5 0.49
Total   1526 100 18 1989 100 21 3515 100 19
  1. Abbreviations : IR incidence rate, NOS not otherwise specified
  2. aPituitary tumors, tumors associated with AIDS, recurrence of tumors, and metastatic tumors were not included in the registry.
  3. bUnique astrocytoma variants correspond to subependymoma (n = 12) subependymal giant cell astrocytoma (n = 7) and pleomorphic xanthoastrocytoma (n = 1).
  4. cMixed gliomas correspond to anaplastic oligoastrocytoma (n = 43) and oligoastrocytoma (n = 54); Germ cell tumors and cysts correspond to germinoma (n = 7), mature teratoma (n = 2), teratoma (n = 1), dermoïd cyst (n = 8), and choriocarcinoma (n = 1).